Safety And Efficacy Of Rifabutin In HIV Patients

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Non-tuberculous Mycobacterial DiseasesTuberculosisInhibition of Disseminated Mycobacterium Avium Complex Disease Associated With HIV Infections
Interventions
DRUG

rifabutin

"Mycobutin® capsules150mg depending on the Investigator prescription. Frequency and duration are according to Package Insert as follows. 1.Tuberculosis : The usual adult dosage for oral use is 150 mg to 300 mg of rifabutin once daily.For the treatment of multiple-drug resistance tuberculosis, the usual dosage for oral use is 300 to 450 mg of rifabutin once daily.~2.Treatment of non-tuberculous mycobacterial diseases (including MAC disease) : The usual adult dosage for oral use is 300 mg of rifabutin once daily.~3.Inhibition of disseminated Mycobacterium avium complex (MAC) disease associated with HIV infections : The usual adult dosage for oral use is 300 mg of rifabutin once daily.."

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY